Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A tablet test aims to catch hidden attention and memory problems after stroke

NCT ID NCT07762274

Diagnosis Sponsor: Umeå University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether a tablet version of the Oxford Cognitive Screen (OCS) can accurately identify cognitive issues like spatial neglect and attention problems in people who have had a stroke. Researchers will compare results from the tablet test with the traditional paper version in stroke survivors and healthy adults across Sweden, the UK, and Italy. The goal is to see if the digital tool can make screening faster and more reliable, potentially improving early diagnosis and rehabilitation planning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tablet-based version of the Oxford Cognitive Screen (OCS), a computerized cognitive screening tool
What this could lead to
If the tablet version works as well as the paper test, it could make cognitive screening after stroke faster and more accurate, helping more people get the right rehabilitation.
What could go wrong
The tablet test may not match the paper version's accuracy, and results from different countries may vary. Early-stage validation means it might not be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

450 people

The number who actually took part.

Started

Mar 2025

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Stroke and healthy control se above

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Confirmed stroke via neuroimaging and/or clinical diagnosis 2. Aged 18 years or older 3. Within 48hrs or up to 2-week of confirmed clinical diagnosis of stroke (first ever or recurrent) 4) Ability to concentrate for 10 minutes, as judged by clinical team 5\) Sufficient English/Italien/Swedish fluency 6) Able and willing to provide informed consent Exclusion criteria 1. Any sensory or perception impairments (e.g., vision or hearing) which preclude the administration of OCS even with reasonable adjustments 2. Any medical or psychiatric conditions or delirium that makes cognitive assessments in appropriate in the 3-day timeframe 3. Severe receptive aphasia (no reliable yes/no responses (\<95% correct response)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive and attention disorders and disturbances are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognition Disorders stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognitive and attention disorders and disturbances Digital health Screening strategy Stroke

Contacts and locations

Locations

  • Danderyd University Hospital, Stockholm, Sweden

    Danderyd, Stockholm County, 18288, Sweden

  • Physical and Rehabilitative Medicine Unit, South-East Tuscany Regional Health Service

    Grosseto, Tuscany, 58100, Italy

  • St George's Hospital, St Georges Hospitals NHS Foundation Trust

    London, England, SW17 0QT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.